Sugi Predict

Sugi Predict / Compounds / SCHEMBL584973

SCHEMBL584973

SCHEMBL584973

Nc1cc2ccccc2c(-c2cccc3ccccc23)c1N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.47
▸ HSD17B10 Q99714 4/20 0.47
▸ HPGD P15428 3/20 0.47
▸ TSHR P16473 2/20 0.47
▸ KEAP1 Q14145 2/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ DHFR P00374 1/20 0.46
▸ CES1 P23141 1/20 0.42
▸ GPR84 Q9NQS5 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ HIF1A Q16665 2/20 0.40
▸ HPRT1 P00492 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ CASP1 P29466 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ CYP1B1 Q16678 1/20 0.39
▸ GAA P10253 2/20 0.39
▸ KDM4E B2RXH2 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29863315 1.00 ALDH1A1 (0.47) ALDH1A1HSD17B10HPGDTSHRKEAP1
SCHEMBL30599052 1.00 ALDH1A1 (0.47) ALDH1A1HSD17B10HPGDTSHRKEAP1
SCHEMBL31442270 0.85 ALDH1A1 (0.47) ALDH1A1HSD17B10HPGDTSHRKEAP1
SCHEMBL12124161 0.84 ALDH1A1 (0.46) ALDH1A1HSD17B10HPGDTSHRKEAP1
SCHEMBL8141507 0.82 DHFR (0.44) ALDH1A1HSD17B10HPGDTSHRKEAP1
SCHEMBL30267509 0.82 DHFR (0.44) ALDH1A1HSD17B10HPGDTSHRKEAP1
SCHEMBL29874641 0.82 HKDC1 (0.49) ALDH1A1HSD17B10HPGDTSHRKEAP1
SCHEMBL30803682 0.82 DHFR (0.44) ALDH1A1HSD17B10HPGDTSHRKEAP1
SCHEMBL29623909 0.82 DHFR (0.44) ALDH1A1HSD17B10HPGDTSHRKEAP1
SCHEMBL338172 0.80 CES1 (0.55) ALDH1A1HSD17B10HPGDTSHRDHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122080405-A High-insulation binaphthyl polyimide dielectric film and preparation method and application thereof — 2026-05-26 — — CN claimed
CN-117659086-B Axis chiral biaryl diphosphine ligand, preparation method and application thereof 中国科学技术大学 2026-05-15 — — CN claimed
CN-119798990-A Resin composition and use thereof 苏州生益科技有限公司 2025-04-11 — — CN claimed
CN-119500260-A Synergistic polyimide photocatalytic powder and preparation method thereof 上海晶顿科技有限公司 2025-02-25 — — CN claimed
CN-119192573-A Modified maleimide prepolymer, resin composition and application thereof 苏州生益科技有限公司 2024-12-27 — — CN claimed
CN-118745141-A No. 5 binaphthyl diisocyanate, synthesis method thereof and application thereof in preparing binaphthyl polyurethane material 青岛科凯达橡塑有限公司 2024-10-08 — — CN claimed
CN-118745140-A No. 4 binaphthyl diisocyanate, synthesis method thereof and application thereof in preparing binaphthyl polyurethane material 青岛科凯达橡塑有限公司 2024-10-08 — — CN claimed
CN-118724756-A 6-Bit binaphthyl diisocyanate, synthesis method thereof and application thereof in preparation of binaphthyl polyurethane material 青岛科凯达橡塑有限公司 2024-10-01 — — CN claimed
CN-118441482-A Preparation method of polyimide-based photocatalytic fiber 上海大学 2024-08-06 — — CN claimed
CN-118439986-A Chiral binuclear thiourea organic catalyst and preparation method and application thereof 苏州源锂新材料科技有限公司 2024-08-06 — — CN claimed
CN-111138312-A Schiff base Cu (II) complex with binaphthyl diamine as framework and preparation method thereof 中国科学院大连化学物理研究所 2020-05-12 — — CN claimed
CN-109503387-A Method for catalyzing asymmetric synthesis of binaphthyl diamine 南方科技大学 2019-03-22 — — CN claimed
CN-104138751-A Chiral core-shell chromatography stationary phase and preparation method UNIV CHINA PHARMA 2014-11-12 — — CN claimed
CN-103293176-A Method for measuring optical purity of chiral carboxylic acid FUJIAN MATTER STRUCTURE 2013-09-11 — — CN claimed
CN-102070529-A Axially chiral imidazole salt compound and preparation method thereof UNIV SOUTH CHINA TECH 2011-05-25 — — CN claimed
EP-1134226-B1 Process for producing an optically active ruthenium-phosphine complex and process for producing an optically active alcohol by using the complex TAKASAGO PERFUMERY CO LTD (JP) 2007-01-03 — — EP claimed
US-20010039354-A1 Process for producing an optically active ruthenium-phosphine complex and process for producing an optically active alcohol by using the complex TAKASAGO INTERNATIONAL CORPORATION (JP) 2001-11-08 — — US claimed
EP-1134226-A2 Process for producing an optically active ruthenium-phosphine complex and process for producing an optically active alcohol by using the complex Takasago International Corporation (JP) 2001-09-19 — — EP claimed
EP-0258967-B2 Process for producing optically active alcohols TAKASAGO PERFUMERY CO LTD (JP) 1996-08-21 — — EP claimed
EP-0258967-A2 Process for producing optically active alcohols Takasago Perfumery Co., Ltd. (JP) 1988-03-09 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010039354-A1 Process for producing an optically active ruthenium-phosphine complex and process for producing an optically active alcohol by using the complex DRD4, PNMT, DRD1 ALDH1A1 1040/4885HSD17B10 4786/4885HPGD 3199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.